Conversely, the inhibition of NaV1.7 using small molecule inhibitors has been shown to reduce cancer cells functions in various pre-clinical models, including decrease in cells migration, invasion, and proliferation in vitro as well as reductions in tumor formation and metastasis in vivo. The gene discussed is SCN9A; the disease is cancer.